phase

82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …

Competing interests GMC serves on the board of directors of Satellite Healthcare, a not-for-profit dialysis provider. His institution (Stanford University) has received grant funding from clinical trial sponsor CSL Behring. …

TFF Pharma Co., Ltd. Oral Presentation Presenting Latest Data from a Phase 2 Study Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TAC FORT WORTH, Texas, March 25, …

Eredon Pharmaceuticals Co., Ltd. IRVINE, Calif., March 25, 2024 (Globe Newswire) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the registration of 12 pharmaceutical companies.th On March 23, 2024, …

Tonix Pharmaceuticals Holding Co., Ltd. Top-line results are expected in the third quarter of 2024.Planning phase 2 trial to prevent kidney transplant rejection Anti-CD40L has multiple potential indications in addition …

Laupacis, A. et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 50, 235–242 (1996). Article  CAS  PubMed  Google Scholar  Wolfe, R. A. et …